Validation, and translational application to address complex challenges in host-pathogen biology. The ten contributions assembled here collectively demonstrate how multi-omics systems biology, artificial intelligence, rigorous statistical validation, regulatory network analysis, and fielddeployable diagnostics converge to reshape our understanding of infectious disease mechanisms and therapeutic intervention strategies. Rather than presenting isolated analytical components, this collection establishes an end-to-end platform supporting the entire discovery lifecycle from in silico hypothesis generation through experimental validation to clinical translation. The works span protozoan parasites (Leishmania, Trypanosoma, Toxoplasma), bacterial pathogens (Leptospira, Streptococcus), host immune modulation, structural biology, nano-enabled therapeutics, and molecular diagnostics, unified by their commitment to methodological rigor and translational relevance.The shift from reductionist to systems-level approaches represents a fundamental paradigm change in host-pathogen research (Loiseau et al., 2020). This framework proves particularly powerful for studying parasites with unique molecular architectures, such as kinetoplastids with their polycistronic transcription and trans-splicing mechanisms (Clayton, 2019). Zhu et al. exemplify this integrative approach by dissecting exosome-mediated nucleic acid delivery in macrophage autophagy and immune reprogramming. Through combined transcriptomic and proteomic profiling identifying 1,363 differentially expressed genes and 384 proteins, they revealed convergent signaling pathways, including AMPK/mTOR and NF-κB, as central regulators of host responses. This work demonstrates how multi-omics analysis can link intracellular signaling, immune modulation, and translational delivery platforms within a unified conceptual framework, establishing exosomes as both mechanistic probes and therapeutic vehicles.Comparative genomics provides complementary systems-level insights. Dubniewicz Artificial intelligence and machine learning have revolutionized therapeutic target identification and validation (Pun et al., 2023). González-García et al. advance Trypanosoma cruzi Nmyristoyltransferase as a drug target through large-scale in silico screening combined with experimental verification, demonstrating selective inhibition and biochemical tractability. This work establishes a reproducible framework for computationally driven target discovery in kinetoplastid parasites, enabling efficient navigation of chemical space while maintaining biological relevance (Chaudhary and Roos, 2005). Structural biology strengthens computational discovery by providing mechanistic context for therapeutic intervention. Tjia-Fleck et al. employ high-resolution cryo-electron microscopy to analyze membrane-bound streptococcal α-enolase in complex with human plasminogen, revealing specific interaction interfaces critical for host tissue invasion. These structural insights inform both target validation and rational inhibitor design, underscoring how computational and experimental methods reinforce one another (Childs-Disney et al., 2022).The synergy between computational prediction and experimental validation extends to resistance mechanisms. Bhusal et al. comprehensively review drug resistance in leishmaniasis, synthesizing evidence showing how genomic plasticity, gene amplification, and regulatory rewiring collectively drive therapeutic failure. Their analysis of multi-layer data integration approaches highlights how computational modeling can distinguish adaptive resistance mechanisms from experimental noise, emphasizing resistance as a dynamic systems property (Dekker, 2024;Hossain et al., 2024).Reproducibility in biomedical research necessitates integrated statistical frameworks from data acquisition through biological interpretation. Strzelecki and Nowicki provide a comprehensive review of tools for studying microbial iron homeostasis and oxidative stress, emphasizing standardized measurement, validation strategies, and cross-platform consistency. By highlighting both current methodological capabilities and critical gaps limiting reproducibility, this work reinforces that statistical rigor is not auxiliary but foundational for translating molecular findings into reliable therapeutic strategies. Methodological standardization proves equally critical in glycomics and proteomics. The saccharide profiling platform developed by Lewicka et al. demonstrates how analytical chemistry advances enable discrimination of closely related bacterial strains, providing orthogonal validation to genomic approaches. Similarly, the multi-omics integration framework employed by Zhu et al. showcases how rigorous statistical validation across transcriptomic and proteomic datasets strengthens mechanistic conclusions about immune reprogramming.The intricate regulatory networks governing host-pathogen interactions involve dynamic interplay of metabolic, immunological, and evolutionary strategies. Shoeran et al. characterize SNF1 kinase homologs in Leishmania major, demonstrating how metabolic regulation contributes to parasite fitness, stress tolerance, and virulence. This work identifies regulatory kinases as promising intervention points while illustrating that targeting network regulators may offer more durable therapeutic strategies than single-target inhibition (Yu et al., 2022;Pang et al., 2022). Parasites showcase remarkable metabolic flexibility and adaptive responses to host-induced stress. The NF-κB pathway serves as a key host immune regulator that pathogens exploit for immune evasion, as demonstrated in the exosomal signaling studies by Zhu et al., while the AMPK/mTOR signaling axis links metabolic status with immune function. Autophagy plays a dual role, aiding pathogen degradation yet being manipulated by parasites for survival, a theme explored through multi-omics...